AIZN is the 5.25% subordinated notes due 2061 issued by Assurant, so the claim being evaluated is a debt security, not the common equity and not a residential REIT, which is how the data sheet classifies it. The sheet's sector and industry labels and its 9.4B market cap refer to the issuer, so they tell you little about the bond's own risk. What matters is Assurant's ability to service a long-dated subordinated obligation, and the sheet offers no operating evidence for that: revenue growth and operating margin read 0.0%, forward P/E is unavailable, and ROE of 7.5% is the only profitability figure given. The score of 26/100 and absence of index membership point the same way. This is a name to skip unless you have separate credit work on Assurant and a specific reason to hold a 2061 subordinated tranche.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 20 Oct 2026, 15:04 CEST | Fair value | $31.09 | $30.74 | $17.11 |
| 20 Oct 2026, 15:04 CEST | Rating | Undervalued | first publication | $17.11 |
| 16 Oct 2026, 00:00 CEST | Fair value | $30.74 | $33.76 | $17.05 |
| 11 Oct 2026, 00:00 CEST | Fair value | $33.76 | $41.61 | $17.38 |
| 10 Oct 2026, 00:00 CEST | ACCE price target | $17.50 | first publication | $17.33 |
| 7 Oct 2026, 00:00 CEST | Fair value | $41.61 | $42.29 | $17.58 |
| 4 Oct 2026, 00:00 CEST | Fair value | $42.29 | $42.95 | $17.75 |
| 30 Sept 2026, 00:00 CEST | Fair value | $42.95 | $44.17 | $18.04 |
| 24 Sept 2026, 00:00 CEST | Fair value | $44.17 | $43.52 | $18.19 |
| 19 Sept 2026, 00:00 CEST | Fair value | $43.52 | $44.11 | $17.88 |
Answered from Assurant Inc. 5.25% Subordinated Notes due 2061 fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| AIZN Assurant Inc. 5.25% Subordinated Notes due 2061 | $17.10 | $31 | 45% below | - | 7.5% | 38 | 26 |
| JAN Janus Living Inc. Class A-1 Common Stock | $28.31 | - | - | - | 0.5% | 27 | 47 |
| CPT Camden Property Trust Common Stock | $102.00 | $103 | 1% below | 33.9x | 7.9% | 72 | 41 |
| ELS Equity Lifestyle Properties Inc. Common Stock | $60.84 | - | - | 29.3x | 22.3% | 77 | 48 |
| AMH American Homes 4 Rent Common Shares of Beneficial Interest | $31.92 | $22 | 42% above | 25.3x | 7.1% | 77 | 55 |
| UDR UDR Inc. Common Stock | $35.84 | $25 | 42% above | 22.7x | 13.7% | 72 | 52 |
| MAA Mid-America Apartment Communities Inc. Common Stock | $119.78 | $105 | 14% above | 35.4x | 7.0% | 69 | 48 |
Where AIZN ranks against its sector peers on each metric.